» Articles » PMID: 32274296

Human Platelet Lysates-Based Hydrogels: A Novel Personalized 3D Platform for Spheroid Invasion Assessment

Overview
Journal Adv Sci (Weinh)
Date 2020 Apr 11
PMID 32274296
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Fundamental physiologic and pathologic phenomena such as wound healing and cancer metastasis are typically associated with the migration of cells through adjacent extracellular matrix. In recent years, advances in biomimetic materials have supported the progress in 3D cell culture and provided biomedical tools for the development of models to study spheroid invasiveness. Despite this, the exceptional biochemical and biomechanical properties of human-derived materials are poorly explored. Human methacryloyl platelet lysates (PLMA)-based hydrogels are herein proposed as reliable 3D platforms to sustain in vivo-like cell invasion mechanisms. A systematic analysis of spheroid viability, size, and invasiveness is performed in three biomimetic materials: PLMA hydrogels at three different concentrations, poly(ethylene glycol) diacrylate, and Matrigel. Results demonstrate that PLMA hydrogels perfectly support the recapitulation of the tumor invasion behavior of cancer cell lines (MG-63, SaOS-2, and A549) and human bone-marrow mesenchymal stem cell spheroids. The distinct invasiveness ability of each cell type is reflected in the PLMA hydrogels and, furthermore, different mechanical properties produce an altered invasive behavior. The herein presented human PLMA-based hydrogels could represent an opportunity to develop accurate cell invasiveness models and open up new possibilities for humanized and personalized high-throughput screening and validation of anticancer drugs.

Citing Articles

Osteosarcoma tumor microenvironment: the key for the successful development of biologically relevant 3D in vitro models.

Rodrigues J, Sarmento B, Leite Pereira C In Vitro Model. 2025; 1(1):5-27.

PMID: 39872973 PMC: 11756501. DOI: 10.1007/s44164-022-00008-x.


Leveraging Blood Components for 3D Printing Applications Through Programmable Ink Engineering Approaches.

Sobreiro-Almeida R, Santos S, Decarli M, Costa M, Correia T, Babilotte J Adv Sci (Weinh). 2024; 11(47):e2406569.

PMID: 39450696 PMC: 11653660. DOI: 10.1002/advs.202406569.


Embedding Bioprinting of Low Viscous, Photopolymerizable Blood-Based Bioinks in a Crystal Self-Healing Transparent Supporting Bath.

Caiado Decarli M, Ferreira H, Sobreiro-Almeida R, Teixeira F, Correia T, Babilotte J Small Methods. 2024; 9(1):e2400857.

PMID: 38970553 PMC: 11740956. DOI: 10.1002/smtd.202400857.


Human Platelet Lysate-Derived Nanofibrils as Building Blocks to Produce Free-Standing Membranes for Cell Self-Aggregation.

Monteiro C, Gomes M, Bharmoria P, Freire M, Coutinho J, Custodio C ACS Nano. 2024; 18(24):15815-15830.

PMID: 38833572 PMC: 11191744. DOI: 10.1021/acsnano.4c02790.


Biomechanical Aspects in Bone Tumor Engineering.

Menshikh K, Banicevic I, Obradovic B, Rimondini L Tissue Eng Part B Rev. 2023; 30(2):217-229.

PMID: 37830183 PMC: 11001506. DOI: 10.1089/ten.TEB.2023.0106.


References
1.
Junttila M, de Sauvage F . Influence of tumour micro-environment heterogeneity on therapeutic response. Nature. 2013; 501(7467):346-54. DOI: 10.1038/nature12626. View

2.
Fong E, Harrington D, Farach-Carson M, Yu H . Heralding a new paradigm in 3D tumor modeling. Biomaterials. 2016; 108:197-213. PMC: 5730082. DOI: 10.1016/j.biomaterials.2016.08.052. View

3.
Bellomo C, Caja L, Moustakas A . Transforming growth factor β as regulator of cancer stemness and metastasis. Br J Cancer. 2016; 115(7):761-9. PMC: 5046208. DOI: 10.1038/bjc.2016.255. View

4.
Babel L, Grunewald M, Lehn R, Langhans M, Meckel T . Direct evidence for cell adhesion-mediated radioresistance (CAM-RR) on the level of individual integrin β1 clusters. Sci Rep. 2017; 7(1):3393. PMC: 5469790. DOI: 10.1038/s41598-017-03414-4. View

5.
Ferreira L, Gaspar V, Mano J . Design of spherically structured 3D in vitro tumor models -Advances and prospects. Acta Biomater. 2018; 75:11-34. PMC: 7617007. DOI: 10.1016/j.actbio.2018.05.034. View